Sign Out
Use in Pregnancy: Ambroxol hydrochloride crosses the placental barrier. Nonclinical studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition or postnatal development.
Tablet: Extensive clinical experience after the 28th week of pregnancy has shown no evidence of harmful effects on the fetus. Nonetheless, the usual precautions regarding the use of drugs during pregnancy should be observed. Especially during the first trimester, the use of Ambroxol is not recommended.
Use in Lactation: Ambroxol hydrochloride is excreted in breast milk. Although unfavorable effects on breastfed infants would not be expected, Ambroxol is not recommended for use in nursing mothers.
